Literature DB >> 1313174

Pancreatic exocrine carcinoma producing adrenocorticotropic hormone.

L Gullo1, R De Giorgio, A D'Errico, W Grigioni, M Parenti, R Corinaldesi.   

Abstract

A rare case of pancreatic exocrine carcinoma with an endocrine component secreting adrenocorticotropic hormone (ACTH) is reported and discussed in relation to other cases previously published. The patient initially presented with a severe form of diabetes, which was treated accordingly. Persistence of hyperglycemia, along with other metabolic alterations and marked hypokalemia, led to the suggestion of abnormal ACTH secretion. In this patient, however, a florid Cushing's syndrome was not observed. The patient also developed hematological alterations, mainly leukopenia and thrombocytopenia, whose origins were unclear. At autopsy, a poorly-defined mass was discovered between the body and tail of the pancreas. Standard histology showed a moderately-differentiated adenocarcinoma. Immunohistochemical analysis of the tumor specimen demonstrated the presence of some neoplastic cells immunoreactive for chromogranin A, neuron-specific enolase and ACTH. These findings are consistent with the existence of an endocrine component within the exocrine carcinoma with ACTH differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313174     DOI: 10.1097/00006676-199203000-00007

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  2 in total

1.  Metastatic pancreatic neuroendocrine carcinoma causing Cushing's syndrome. ACTH secretion by metastases 3 years after resection of nonfunctioning primary cancer.

Authors:  L Zhu; D R Domenico; J M Howard
Journal:  Int J Pancreatol       Date:  1996-06

2.  Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.

Authors:  N Ohike; A Jürgensen; M Pipeleers-Marichal; G Klöppel
Journal:  Virchows Arch       Date:  2003-02-06       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.